drugset / Trial / NCT02645409

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

NCT02645409 ↗

Completed 14 enrolled Chandru Sundaram
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Primary • To explore the use of OTL38 and fluorescence imaging to detect RCC in partial nephrectomy at the margins of resection, and in lymph node(s) or other metastases during radical nephrectomy.

Timeline

Start
2015-12-29
Primary completion
2018-03-20
Completion
2019-04-02

Drugs

EvaluationDrugModalityDoseRoute
Subject pafolacianine Diagnostic / imaging agent — —

Indications